Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS
Content archived on 2024-06-18

Siglecs as mediators of the pancreatic cellular crosstalk in diabetes

Objective

The mechanisms of the immune and endocrine cell interaction within the islet and resulting β-cell death are
highly complex and largely unknown. To investigate the cellular crosstalk in the pancreas and how its
disturbance leads to insufficient insulin production is important to understand the pathology of the disease. This
is the major goal of this project.
Activation of inflammation is not only a trigger for β-cell destruction, but also a major factor for the metabolic
syndrome, including insulin resistance and complications of diabetes.
Signalling and activation of immune cells is facilitated by secreted pro-inflammatory stimulators and via cell-cell
interactions. I propose that a group of adhesion and signalling molecules, the Siglecs (sialic acid–binding
immunoglobulin (Ig)-like lectins) mediate such interactions. They are responsible for immune system activation
and have been initially found in cells of hematopoietic origin. I made the groundbreaking observation of cell
type specific Siglec expression in the human pancreas: Siglecs were differentially expressed in glucagon
producing α-cells, and in insulin producing β-cells. A diabetic milieu had an inductive effect on Siglec
expression in the α-cells, but lead to decreased β-cell specific Siglecs. This loss of Siglecs in the β-cell could be
detrimental and result in an excessive cytokine release and in turn switches on Siglec responses in neighbouring
cells. In my proposed studies I will investigate the role of Siglecs in the cellular network in islets and in the
circulation to probe whether changes in Siglec expression are causative in the development of diabetes.
My project is a pioneer and multidisciplinary study combining the current knowledge of glycobiochemistry
and β-cell biology in diabetes. The project uses multi-model cell systems of healthy and diseased human
pancreatic tissue, isolated human islets, isolated human β-cells as well as diabetic mouse models, all of them
being absolutely novel and high-risk to a large extend.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.

You need to log in or register to use this function

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

ERC-2010-StG_20091118
See other projects for this call

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

ERC-SG - ERC Starting Grant

Host institution

UNIVERSITAET BREMEN
EU contribution
€ 1 363 847,00
Address
Bibliothekstrasse 1
28359 Bremen
Germany

See on map

Region
Bremen Bremen Bremen, Kreisfreie Stadt
Activity type
Higher or Secondary Education Establishments
Links
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

No data

Beneficiaries (1)

My booklet 0 0